The OTS Annual Meeting brings together leading researchers and industry experts to advance the field of oligonucleotide therapeutics. This premier event fosters collaboration and knowledge sharing, covering a wide range of topics, including antisense, siRNA, immunostimulatory, and aptamer technologies, as well as RNA/DNA editing and mRNA therapeutics. Attendees, from seasoned scientists to aspiring researchers, have the opportunity to engage in insightful discussions, present groundbreaking research, and network with peers.

Bachem participates in this event.